Neoleukin Therapeutics Inc

-

Assets, Funds, Holdings

Home | Sign Up | Log In
New Features
Latest Fund Raises
Related People
Fund Service Providers
Startup & Company Raises
List of Funds
Boston Firms
Boston Hedge Funds
Cornell Alumni Firms
CalPERS Portfolio
NYSCRF Portfolio
User Guide
Regulatory AUM vs AUM
LP Portfolios
Related Firms
Build a Portfolio
Comprehensive Search
Keyboard
Neoleukin Therapeutics Inc
CIK #0001404644
EDGAR Form CIK 2011 - 2026
10-K [0001404644]
10-Q [0001404644]
3 [0001404644]
4 [0001404644]
5 [0001404644]
8-K [0001404644]
D [0001404644]
SC 13D [0001404644]
SC 13G [0001404644]
Form 13D/13G Filer Form 13D/13G Subject Filed
Trails Edge Capital Partners LP Neurogene Inc [2025-12-15]
Baker Bros Advisors LP Neurogene Inc [2025-05-15]
Commodore Capital LP Neurogene Inc [2024-12-11]
RTW Investments LP Neurogene Inc [2024-11-14]
FMR LLC Neurogene Inc [2024-11-12]
Casdin Capital LLC Neurogene Inc [2024-11-08]
BlackRock Inc Neurogene Inc [2024-07-08]
Samsara Biocapital LP Neurogene Inc [2024-02-14]
Cormorant Asset Management LP Neurogene Inc [2024-02-14]
EcoR1 Capital LLC Neurogene Inc [2024-02-14]
View All
Form 3/4/5 Subject 2011 - 2026
Aquinox Pharmaceuticals Inc
Cvijic Christine Mikail
Shafer Christina
Jordan Julie
McMinn Rachel
Cobb Stuart
Palekar Rohan
Noonberg Sarah B
Freedland Cory S
Baffi Robert
Woods Keith
Woods Robert Keith
Samsara BioCapital GP LLC
Akkaraju Srinivas
Samsara BioCapital LP
Baker Brothers Life Sciences LP
Baker Bros Advisors GP LLC
667 LP
Baker Julian
Baker Felix
Baker Bros Advisors LP
Smith Sean Michael
Lavelle Erin
Simpson Todd E
Babler Martin
Patel Priti
Drachman Jonathan G
Cochener Donna
Walkey Carl
Ho Robert
Vance Holly
Williams Lewis T
Lavelle Erin M
Nolan Sean P
Redmile Group LLC
Green Jeremy
Boyd Meta Cantey
Main David
McCloskey Shelley
MacKenzie Lloyd
Alam Kamran
Levitt Daniel J
Bridger Gary
Pelzer Robert
Troupin Barbara
Jenkins Abigail
Neu Kelvin
Levy Richard S
Mitchell David Chilton
Shrewsbury Stephen B
Johnson & Johnson
Johnson & Johnson Development Corp ET AL
Pfizer Inc
Ventures West 8 Limited Partnership
Jones Elaine V
Insider Transaction (Form 3/4/5) Date Action Shares Price Value ($)
Aquinox Pharmaceuticals Inc NGNE
Common Stock
2026-03-26 Sell 828 $21.89 18,125
Aquinox Pharmaceuticals Inc NGNE
Common Stock
2026-03-26 Sell 2,558 $21.62 55,304
Aquinox Pharmaceuticals Inc NGNE
Common Stock
2026-03-26 Sell 3,352 $22.07 73,979
Aquinox Pharmaceuticals Inc NGNE
Common Stock
2026-03-13 Sell 263 $22.02 5,791
Aquinox Pharmaceuticals Inc NGNE
Common Stock
2026-03-13 Sell 2,658 $21.34 56,722
Aquinox Pharmaceuticals Inc NGNE
Common Stock
2026-03-13 Sell 148 $22.08 3,268
Aquinox Pharmaceuticals Inc NGNE
Common Stock
2026-03-13 Sell 2,387 $20.42 48,743
Aquinox Pharmaceuticals Inc NGNE
Common Stock
2026-03-13 Sell 3,991 $20.41 81,456
Aquinox Pharmaceuticals Inc NGNE
Common Stock
2026-03-13 Sell 1,395 $21.25 29,644
Aquinox Pharmaceuticals Inc NGNE
Common Stock
2026-02-27 Sell 4,800 $25.11 120,528
Aquinox Pharmaceuticals Inc NGNE
Common Stock
2026-02-20 Grant 22,000 $0.00
Aquinox Pharmaceuticals Inc NGNE
Common Stock
2026-02-20 Grant 16,500 $0.00
Aquinox Pharmaceuticals Inc NGNE
Non-Qualified Stock Option (right to buy) · derivative
2026-02-20 Grant 12,050 $0.00
Aquinox Pharmaceuticals Inc NGNE
Common Stock
2026-02-20 Grant 25,900 $0.00
Aquinox Pharmaceuticals Inc NGNE
Non-Qualified Stock Option (right to buy) · derivative
2026-02-20 Grant 12,050 $0.00
Aquinox Pharmaceuticals Inc NGNE
Stock Option (Right to Buy) · derivative
2026-02-20 Grant 131,900 $0.00
Aquinox Pharmaceuticals Inc NGNE
Non-Qualified Stock Option (right to buy) · derivative
2026-02-20 Grant 12,050 $0.00
Aquinox Pharmaceuticals Inc NGNE
Stock Option (Right to Buy) · derivative
2026-02-20 Grant 155,100 $0.00
Aquinox Pharmaceuticals Inc NGNE
Non-Qualified Stock Option (right to buy) · derivative
2026-02-20 Grant 12,050 $0.00
Aquinox Pharmaceuticals Inc NGNE
Common Stock
2026-02-20 Grant 4,900 $0.00
showing 20 of 200 most recent transactions
Terms | Privacy | Providers | Companies | Guide
tony@aum13f.com